Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung SDI (006400) – Hana Securities | Turnaround to Profit · North America ESS Ramp-Up · Valuation Upside / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · HBM · Valuation Re-rating / 2026-06-22 Research
  • [Research] Samsung Biologics (207940) – Shinhan Securities | Rockville Revenue Recognition · Guidance Revision Potential · Songdo Plant 6 Groundbreaking / 2026-04-23 Research
  • [Research] LIG D&A (079550) – Hanwha Investment & Securities | 4Q25 Review · Ghost Robotics Impairment Cleared · Margin Expansion / 2026-02-23 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI Demand · Supply Tightness · Margin Expansion / 2026-08-11 Research
  • [Research] Hanwha Ocean (042660) – Kiwoom | Merchant Profit Driver · High-Price Mix Scale-Up · Naval & Offshore Orders / 2026-04-29 Shipbuilding
  • [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Commencing Customer T ESS Business (Estimated) · SDC Asset Utilization · Valuation Gap Narrowing / 2026-02-03 Research

[Research] SK hynix (000660 / SKHY) – Hyundai Motor | Supply Shortage · Memory ASP · Profitability / 2026-01-30

Posted on January 30, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Hyundai Motor Securities

Analyst : Keun-chang Noh (RA: Dong-wook Yoon)

Investment Rating : BUY (Maintained)

Target Price : 1,000,000 KRW (Raised)

Core Momentum : Intensifying memory supply shortages are expected to drive sharp ASP increases across both commodity and high-value products, while HBM4 shipments and sustained pricing strength support a structural improvement in profitability.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price: 1,000,000 KRW (Based on Target P/B 2.94x to 2026F BPS)
  • Investment Rating: BUY (Maintained)
  • 2026F Financial Outlook: Revenue 295.29 trillion KRW, Operating Profit 148.16 trillion KRW
  • EPS: 177,847 KRW (2026F)
  • Valuation Multiples: P/E 4.8x, P/B 2.5x, EV/EBITDA 3.3x

🚀 2. [Market Opportunities & Business Outlook]

  • Intensifying Supply Shortage: The memory industry is facing a severe supply shortage, suggesting that actual ASP increases for DRAM and NAND could exceed current projections.
  • ASP & Product Mix: Q1 DRAM and NAND ASP are expected to rise by 64.8% and 60.0% QoQ, respectively, facilitating a structural level-up in profitability.
  • HBM Leadership: HBM4 products are scheduled for delivery to key clients in Q2, with HBM revenue projected to more than double YoY in 2026.
  • Earnings Outlook: ASP for product lines including generic DRAM and eSSD is expected to continue its upward trend, rising by over 20% QoQ in Q2 2026.

📝 Editor’s Comment (Perspective)

The analyst views SK hynix not merely as a manufacturer sensitive to short-term memory price fluctuations, but as a company achieving a structural leap in profitability by capturing massive ASP surges across both premium and generic memory products, fueled by aggressive AI infrastructure investment. The analyst emphasizes the high elasticity of profit margins in the current supply-constrained environment.

To verify this investment thesis, one should monitor whether the actual DRAM and NAND ASP growth rates align with the projections, if HBM4 products are successfully supplied to key clients in Q2, and if ASP for generic memory products continues to rise by over 20% QoQ in Q2 2026. These metrics can be tracked through upcoming quarterly earnings releases, official IR materials, and periodic corporate reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – DS Investment | Server Memory Demand · HBM3E Pricing · Margin Expansion / 2026-01-30
Next Post: [Research] ABL Bio (298380) – DS Investment & Securities | Sanofi Strategy · Grabody B Validity · Muscle Shuttle Expansion / 2026-02-02

Related Posts

  • [Research] Hanwha Ocean (042660) – Hana Securities | Merchant Vessel Margin Expansion · Energy Supply Chain Shift · Order Momentum / 2026-07-28 Research
  • [Research] LIG D&A (079550) – Shinhan Securities | 1Q26 Surprise · Demand Surge · Long-term Compounding / 2026-05-08 Research
  • [Research] Samsung SDI (006400) – iM Securities | US ESS Market Share Gains · Mid-Term ESS OP of KRW 1.4T · 4Q Loss Narrowing / 2026-02-03 Research
  • [Research] LIG D&A (079550) – SK Securities | Modern Warfare Leader · Limited Global CapEx · Multiple Re-rating / 2026-04-07 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | HBM4 · Product Mix · LTA / 2026-07-30 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Server CPU Demand · HBM Diversification · HBM4 / 2026-05-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | MLCC Price Cycle · Customer Prepayments · Server Demand / 2026-08-11 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18 Research
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Contract Pricing · LTA · DRAM Supply Shortage / 2026-04-09 Research
  • [Research] LigaChem Biosciences (141080) – iM Securities | Clinical Data · Pipeline Progress · Tech Transfer / 2026-05-21 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Hyperscaler Capex · Custom HBM · Inference Memory Demand / 2026-05-04 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | US ESS Demand Surges · BBU Growth · 4Q26 Turnaround / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Supply Discipline · LTA · Shareholder Returns / 2026-07-30 Research
  • [Research] Hanwha Ocean (042660) – iM Securities | Merchant Profit Surprise · Special Ship Sentiment · Valuation De-rating / 2026-07-28 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme